伏格列波糖 - CAS:83480-29-9 - CAS号查询_生物试剂_化学试剂_分析试剂

中文名称:	伏格列波糖
英文名称:	Voglibose
别名:	(1S,2S,3R,4S,5S)-5-((1,3-二羟丙基-2-基)氨基)-1-(羟甲基)环己烷-1,2,3,4-四醇 Glustat；(1S,2S,3R,4S,5S)-5-((1,3-Dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol
CAS No:	83480-29-9	分子式:	C₁₀H₂₁NO₇	分子量:	267.28
CAS No:	83480-29-9
分子式:	C₁₀H₂₁NO₇
分子量:	267.28
EINEC:	4540
EINEC:	4540

安全技术说明书(PDF) MSDS(PDF) 点击下载产品说明书(PDF) 点击下载技术规格说明书(PDF)

V10168 伏格列波糖 ≥98% (psaitong)

相关产品

包装规格：

250mg 1g 5g in glass bottle

溶解性：

溶于DMSO(100mg/ml 超声)

产品描述：

valiolamine的衍生物,抑制α-葡萄糖苷酶，可作用于高血糖症等。
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose was first launched in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus. Postprandial hyperglycemia (PPHG) is primarily due to first phase insulin secretion. Alpha glucosidase inhibitors delay glucose absorption at the intestine level and thereby prevent sudden surge of glucose after a meal. There are three drugs which belong to this class, acarbose, miglitol and voglibose, of which voglibose is the newest. Voglibose has fewer side effects than both acarbose and miglitol. But acarbose has an edge over voglibose in terms of efficacy (FPG, PPHG, HBA1c).

保存条件：

-20℃

UN码：

HazardClass：

危害声明：

安全说明：

点击下载核磁/氢谱图谱(PDF)

搜索质检报告(COA)

参考文献 & 客户发表文献